23 May 2013
Keywords: hana, biosci, loss, deepens, 10m, biosciences, usa-based
Article | 27 March 2006
Hana Biosciences, a USA-based biopharmaceutical company focused on cancer, reported a net loss of $10.0 million, or $0.57 per share, for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 March 2006
© 2013 thepharmaletter.com